Omega-3 Fatty Acids and Health. A Literature Review
DOI:
https://doi.org/10.12775/QS.2025.41.60187Keywords
dietary supplements, DHA, EPA, omega-3 fatty acidsAbstract
Introduction and Purpose: Omega-3 polyunsaturated fatty acids (PUFAs) are essential nutrients primarily obtained from marine sources. These compounds, particularly EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), play a critical role in modulating inflammation, supporting cardiovascular and neurological health, and potentially preventing certain cancers. Despite extensive research, mixed clinical results highlight the need for comprehensive analyses. This study aims to synthesize findings on omega-3’s effects on cardiovascular health, neurocognitive development, inflammation, and bioavailability challenges, with a particular focus on research published between 2012 and 2024.
Methodology: The review is based on the thorough analysis of the materials selected from “PubMed” and “Google Scholar” scientific databases from 2012 to 2024 using the following key words: dietary supplements, DHA, EPA, omega-3 fatty acids. These key words were chosen based on their relevance to the matter of an article.
Conclusions: Omega-3 fatty acids demonstrate notable benefits in reducing inflammation, improving lipid profiles, enhancing cognitive function, and lowering the risk of cardiovascular events. However, results regarding the efficacy of omega 3 in the prevention and treatment of chronic disease are inconsistent, due to differences in dosage, bioavailability and study design.
References
1. Marciniak-Lukasiak K. Rola i znaczenie kwasów tłuszczowych omega-3. Żywność Nauka Technologia Jakość. 2011;18(6). DOI: 10.15193/zntj/2011/79/024-035
2. Spiller GA. Lipids in human nutrition. CRC Press, New York. P; 1996.
3. Niewiadomski H. Technologia tłuszczów jadalnych. Wydawnictwa Naukowo-Techniczne; 1979.
4. Ziemlanski S, Budzynska-Topolowska J. Wspolczesne poglady na role fizjologiczna wielonienasyconych kwasow tluszczowych z rodziny N-3. Żywienie Człowieka i Metabolizm. 1992;19(2):100-13.
5. Bartnikowska E. Fizjologiczne działanie polienowych kwasów tłuszczowych z rodziny n-3. Tłuszcze Jadalne. 2008;43(1):2.
6. Flachs P, Rossmeisl M, Bryhn M, Kopecky J. Cellular and molecular effects of n− 3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clinical science. 2009 Jan 1;116(1):1-6.
DOI: 10.1042/cs20070456
7. Kolanowski W. Bioavailability of omega-3 PUFA from foods enriched with fish oil-a mini review.
8. Ziemlanski S. Tluszcze w zywieniu czlowieka. Żywienie Człowieka i Metabolizm. 1997;24(2):35-48.
9. Behr SR. Effects of fish oil and vegetable oil formule on platelet agregation and neutrophils. Am. J. Clin. Nutr. 1994;5:717.
10. Friedman A, Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clinical Journal of the American Society of Nephrology. 2006 Mar 1;1(2):182-92. DOI: 10.2215/cjn.00740805
11. Namiki M. Nutraceutical functions of sesame: a review. Critical reviews in food science and nutrition. 2007 Sep 27;47(7):651-73. DOI: 10.1080/10408390600919114
12. Whelan J, Rust C. Innovative dietary sources of n-3 fatty acids. Annu. Rev. Nutr.. 2006 Aug 21;26(1):75-103. DOI: 10.1146/annurev.nutr.25.050304.092605
13. De Carvalho CC, Caramujo MJ. The various roles of fatty acids. Molecules. 2018 Oct 9;23(10):2583.
DOI: 10.3390/molecules23102583
14. Zhang H, Dhalla NS. The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease. International Journal of Molecular Sciences. 2024 Jan 16;25(2):1082. DOI: 10.3390/ijms25021082
15. Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Advances in nutrition. 2012 Jan 1;3(1):1-7. DOI: 10.3945/an.111.000893
16. Bouwens M, Van De Rest O, Dellschaft N, Bromhaar MG, De Groot LC, Geleijnse JM, Müller M, Afman LA. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. The American journal of clinical nutrition. 2009 Aug 1;90(2):415-24. DOI: 10.3945/ajcn.2009.27680
17. Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S, Hoseini M, Parizade SM, Farhoudi F, Hosseininezhad SJ, Tavallaei S, Vejdani A, Azimi-Nezhad M, Shakeri MT. Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta cardiologica. 2009 Jun 1;64(3):321-7. DOI: 10.2143/ac.64.3.2038016
18. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. The lancet. 2007 Mar 31;369(9567):1090-8. DOI: 10.1016/s0140-6736(07)60527-3
19. Oikawa S, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Sasaki J, Hishida H, Itakura H, Kita T. Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis. 2009 Oct 1;206(2):535-9.
20. Kromhout D, Giltay EJ, Geleijnse JM. n–3 Fatty acids and cardiovascular events after myocardial infarction. New England Journal of Medicine. 2010 Nov 18;363(21):2015-26. DOI: 10.1056/nejmoa1003603
21. Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H, Gottwik M, Steinbeck G, Del Castillo U, Sack R, Worth H. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010 Nov 23;122(21):2152-9. DOI: 10.1161/circulationaha.110.948562
22. Dawczynski C, Martin L, Wagner A, Jahreis G. n− 3 LC-PUFA-enriched dairy products are able to reduce cardiovascular risk factors: A double-blind, cross-over study. Clinical Nutrition. 2010 Oct 1;29(5):592-9. DOI: 10.1016/j.clnu.2010.02.008
23. Cawood AL, Ding R, Napper FL, Young RH, Williams JA, Ward MJ, Gudmundsen O, Vige R, Payne SP, Ye S, Shearman CP. Eicosapentaenoic acid (EPA) from highly concentrated n− 3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis. 2010 Sep 1;212(1):252-9. DOI: 10.1016/j.atherosclerosis.2010.05.022
24. Gajos G, Rostoff P, Undas A, Piwowarska W. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study. Journal of the American College of Cardiology. 2010 Apr 20;55(16):1671-8. DOI: 10.1016/j.jacc.2009.11.080
25. Visioli F, Agostoni C. Omega 3 fatty acids and health: the little we know after all these years. Nutrients. 2022 Jan 6;14(2):239. DOI: 10.3390/nu14020239
26. Harris WS, Del Gobbo L, Tintle NL. The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies. Atherosclerosis. 2017 Jul 1;262:51-4. DOI: 10.1016/j.atherosclerosis.2017.05.007
27. Dixon DL. Catch of the day: icosapent ethyl for reducing cardiovascular risk. The American Journal of Medicine. 2020 Jul 1;133(7):802-4. DOI: 10.1016/j.amjmed.2020.03.006
28. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. The Lancet. 1999 Aug 7;354(9177):447-55. DOI: 10.1016/s0140-6736(99)07072-5
29. Weylandt KH, Serini S, Chen YQ, Su HM, Lim K, Cittadini A, Calviello G. Omega‐3 polyunsaturated fatty acids: the way forward in times of mixed evidence. BioMed research international. 2015;2015(1):143109. DOI: 10.1155/2015/143109
30. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005 Nov 1;112(18):2762-8. DOI: 10.1161/circulationaha.105.549527
31. ORIGIN Trial Investigators. n–3 fatty acids and cardiovascular outcomes in patients with dysglycemia. New England Journal of Medicine. 2012 Jul 26;367(4):309-18. DOI: 10.1056/nejmoa1203859
32. Falck JR, Wallukat G, Puli N, Goli M, Arnold C, Konkel A, Rothe M, Fischer R, Müller DN, Schunck WH. 17 (R), 18 (S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure–activity relationships and stable analogues. Journal of medicinal chemistry. 2011 Jun 23;54(12):4109-18. DOI: 10.1021/jm200132q
33. Nichols PD, McManus A, Krail K, Sinclair AJ, Miller M. Recent advances in omega-3: Health benefits, Sources, Products and bioavailability. Nutrients. 2014 Sep 16;6(9):3727-33. DOI: 10.3390/nu6093727
34. Von Schacky C. Omega-3 index and cardiovascular health. Nutrients. 2014 Feb;6(2):799-814. DOI: 10.3390/nu6020799
35. Howe PR, Coates AM, Buckley JD. Omega-3 Index—Beyond Heart Health. Nutrients. 2014;6:1850-60.
36. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Archives of neurology. 2006 Oct 1;63(10):1402-8. DOI: 10.1001/archneur.63.10.1402
37. Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues JF, Touchon J, Vellas B, MAPT Study Group. Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Alzheimer's & Dementia. 2009 Mar 1;5(2):114-21. DOI: 10.1016/j.jalz.2009.01.008
38. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, Lawlor B, Coakley D, Gibney MJ. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study. British journal of nutrition. 2003 Apr;89(4):483-9. DOI: 10.1079/bjn2002804
39. Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N. Food combination and Alzheimer disease risk: a protective diet. Archives of neurology. 2010 Jun 1;67(6):699-706. DOI: 10.1001/archneurol.2010.84
40. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem N, Frautschy SA, Cole GM. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. Journal of Neuroscience. 2005 Mar 23;25(12):3032-40. DOI: 10.1523/jneurosci.4225-04.2005
41. Freund-Levi Y, Hjorth E, Lindberg C, Cederholm T, Faxen-Irving G, Vedin I, Palmblad J, Wahlund LO, Schultzberg M, Basun H, Eriksdotter Jönhagen M. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer’s disease: the OmegAD study. Dementia and geriatric cognitive disorders. 2009 May 12;27(5):481-90. DOI: 10.1159/000218081
42. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR, Weiner M, Shinto L. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. Jama. 2010 Nov 3;304(17):1903-11. DOI: 10.1001/jama.2010.1510
43. Stonehouse W. Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials. Nutrients. 2014 Jul 22;6(7):2730-58. DOI: 10.3390/nu6072730
44. Judge MP, Harel O, Lammi-Keefe CJ. Maternal consumption of a docosahexaenoic acid–containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. The American journal of clinical nutrition. 2007 Jun 1;85(6):1572-7. DOI: 10.1093/ajcn/85.6.1572
45. Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P, DOMInO Investigative Team. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. Jama. 2010 Oct 20;304(15):1675-83. DOI: 10.1001/jama.2010.1507
46. Furuhjelm C, Warstedt K, Larsson J, Fredriksson M, Böttcher MF, Fälth‐Magnusson K, Duchén K. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta paediatrica. 2009 Sep;98(9):1461-7. DOI: 10.1111/j.1651-2227.2009.01355.x
47. United States. Dietary Guidelines Advisory Committee. Dietary guidelines for Americans, 2010. US Department of Health and Human Services, US Department of Agriculture; 2010.
48. Harper M, Thom E, Klebanoff MA, Thorp Jr J, Sorokin Y, Varner MW, Wapner RJ, Caritis SN, Iams JD, Carpenter MW, Peaceman AM. Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Obstetrics & Gynecology. 2010 Feb 1;115(2 Part 1):234-42. DOI:10.1097/aog.0b013e3181cbd60e
49. Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB. Omega-3 fatty acid-derived mediators 17 (R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. The Journal of Immunology. 2011 Aug 15;187(4):1957-69. DOI: 10.4049/jimmunol.1101305
50. González‐Périz A, Planaguma A, Gronert K, Miquel R, López‐Parra M, Titos E, Horrillo R, Ferré N, Deulofeu R, Arroyo V, Rodés J. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA. The FASEB Journal. 2006 Dec;20(14):2537-9. DOI: 10.1096/fj.06-6250fje
51. Neuhofer A, Zeyda M, Mascher D, Itariu BK, Murano I, Leitner L, Hochbrugger EE, Fraisl P, Cinti S, Serhan CN, Stulnig TM. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes. 2013 Jun 1;62(6):1945-56.
DOI: 10.2337/db12-0828
52. Endo J, Sano M, Isobe Y, Fukuda K, Kang JX, Arai H, Arita M. 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload–induced maladaptive cardiac remodeling. Journal of Experimental Medicine. 2014 Jul 28;211(8):1673-87. DOI: 10.1084/jem.20132011
53. Miller MR, Pearce L, Bettjeman BI. Detailed distribution of lipids in Greenshell™ Mussel (Perna canaliculus). Nutrients. 2014 Apr 11;6(4):1454-74. DOI: 10.3390/nu6041454
54. Murphy K, Howe P. Proceedings of the 2013 Meeting of the Australasian Section of the American Oil Chemists Society (AAOCS). DOI: 10.3390/nu5125065
55. Kitessa SM, Abeywardena M, Wijesundera C, Nichols PD. DHA-containing oilseed: a timely solution for the sustainability issues surrounding fish oil sources of the health-benefitting long-chain omega-3 oils. Nutrients. 2014 May 22;6(5):2035-58. DOI: 10.3390/nu6052035
56. Nichols PD, Glencross B, Petrie JR, Singh SP. Readily available sources of long-chain omega-3 oils: is farmed Australian seafood a better source of the good oil than wild-caught seafood?. Nutrients. 2014 Mar;6(3):1063-79. DOI: 10.3390/nu6031063
57. Bengtson Nash S, Nichols P, Schlabach M. The Nutritional-Toxicological Conflict Associated with Antarctic Krill Oil Dietary Supplements vs. Fish Oil Alternatives. InSETAC Europe 24th Annual Meeting 2014.
58. Petrie JR, Shrestha P, Belide S, Kennedy Y, Lester G, Liu Q, Divi UK, Mulder RJ, Mansour MP, Nichols PD, Singh SP. Metabolic engineering Camelina sativa with fish oil-like levels of DHA. PloS one. 2014 Jan 21;9(1):e85061. DOI: 10.1371/journal.pone.0085061
59. Mansour MP, Shrestha P, Belide S, Petrie JR, Nichols PD, Singh SP. Characterization of oilseed lipids from “DHA-producing Camelina sativa”: A new transformed land plant containing long-chain omega-3 oils. Nutrients. 2014 Feb 21;6(2):776-89. DOI: 10.3390/nu6020776
60. Thyagarajan T, Puri M, Vongsvivut J, Barrow CJ. Evaluation of bread crumbs as a potential carbon source for the growth of Thraustochytrid species for oil and omega-3 production. Nutrients. 2014 May 23;6(5):2104-14. DOI: 10.3390/nu6052104
61. Calviello G, Serini S, Piccioni E. n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Current medicinal chemistry. 2007 Dec 1;14(29):3059-69. DOI: 10.2174/092986707782793934
62. Serini S, Fasano E, Piccioni E, Cittadini AR, Calviello G. Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved. Current Medicinal Chemistry. 2011 Sep 1;18(26):4065-75. DOI: 10.2174/092986711796957310
63. Ghosh S, DeCoffe D, Brown K, Rajendiran E, Estaki M, Dai C, Yip A, Gibson DL. Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PloS one. 2013 Feb 6;8(2):e55468. DOI: 10.1371/journal.pone.0055468
64. Jia Q, Lupton JR, Smith R, Weeks BR, Callaway E, Davidson LA, Kim W, Fan YY, Yang P, Newman RA, Kang JX. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer research. 2008 May 15;68(10):3985-91. DOI: 10.1158/0008-5472.can-07-6251
65. Nowak J, Weylandt KH, Habbel P, Wang J, Dignass A, Glickman JN, Kang JX. Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids. Carcinogenesis. 2007 Sep 1;28(9):1991-5. DOI: 10.1093/carcin/bgm166
66. Schmöcker C, Weylandt KH, Kahlke L, Wang J, Lobeck H, Tiegs G, Berg T, Kang JX. Omega‐3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology. 2007 Apr;45(4):864-9. DOI: 10.1002/hep.21626
67. Weylandt KH, Nadolny A, Kahlke L, Köhnke T, Schmöcker C, Wang J, Lauwers GY, Glickman JN, Kang JX. Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2008 Nov 1;1782(11):634-41. DOI: 10.1016/j.bbadis.2008.08.011
68. Turk HF, Monk JM, Fan YY, Callaway ES, Weeks B, Chapkin RS. Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing. American Journal of Physiology-Cell Physiology. 2013 May 1;304(9):C905-17. DOI: 10.1152/ajpcell.00379.2012
69. Im DS. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Progress in lipid research. 2012 Jul 1;51(3):232-7. DOI: 10.1016/j.plipres.2012.02.003
70. Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2015 Apr 1;1851(4):469-84. DOI: 10.1016/j.bbalip.2014.08.010
71. Anti M, Marra G, Armelao F, Bartoli GM, Ficarelli R, Percesepe A, De Vitis I, Maria G, Sofo L, Rapaccini GL, Gentiloni N. Effect of ω-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology. 1992 Sep 1;103(3):883-91. DOI: 10.1016/0016-5085(92)90021-p
72. Yang T, Fang S, Zhang HX, Xu LX, Zhang ZQ, Yuan KT, Xue CL, Yu HL, Zhang S, Li YF, Shi HP. N-3 PUFAs have antiproliferative and apoptotic effects on human colorectal cancer stem-like cells in vitro. The Journal of nutritional biochemistry. 2013 May 1;24(5):744-53. DOI: 10.1016/j.jnutbio.2012.03.023
73. De Carlo F, Witte TR, Hardman WE, Claudio PP. Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. PLoS One. 2013 Jul 16;8(7):e69760. DOI: 10.1371/journal.pone.0069760
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Damian Machaj, Julia Stawińska-Dudek, Wiktoria Józefowicz, Martyna Brzoza
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 74
Number of citations: 0
